Cargando…
Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1
We have recently shown that induction of the p53 tumour suppressor protein by the small-molecule RITA (reactivation of p53 and induction of tumour cell apoptosis; 2,5-bis(5-hydroxymethyl-2-thienyl)furan) inhibits hypoxia-inducible factor-1α and vascular endothelial growth factor expression in vivo a...
Autores principales: | Ahmed, A, Yang, J, Maya-Mendoza, A, Jackson, D A, Ashcroft, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122121/ https://www.ncbi.nlm.nih.gov/pubmed/21593792 http://dx.doi.org/10.1038/cddis.2011.42 |
Ejemplares similares
-
CHK2 is involved in the p53-independent radiosensitizing effects of valproic acid
por: Choo, Dong Wan, et al.
Publicado: (2017) -
Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing
por: Feijoo, Carmen, et al.
Publicado: (2001) -
Chk2 and p53 Are Haploinsufficient with Dependent and Independent Functions to Eliminate Cells after Telomere Loss
por: Kurzhals, Rebeccah L., et al.
Publicado: (2011) -
Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway
por: Vitale, Ilio, et al.
Publicado: (2007) -
ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene
por: Lee, Hani, et al.
Publicado: (2016)